This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan 6;364(1):81-2.

doi: 10.1056/NEJMe1011211.

Antibiotic therapy for the irritable bowel syndrome

Jan Tack

PMID: 21208112
DOI: 10.1056/NEJMe1011211

Editorial

Antibiotic therapy for the irritable bowel syndrome

Jan Tack. N Engl J Med. 2011.

. 2011 Jan 6;364(1):81-2.

doi: 10.1056/NEJMe1011211.

Author

Jan Tack

PMID: 21208112
DOI: 10.1056/NEJMe1011211

No abstract available

PubMed Disclaimer

Comment on

Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP; TARGET Study Group. Pimentel M, et al. N Engl J Med. 2011 Jan 6;364(1):22-32. doi: 10.1056/NEJMoa1004409. N Engl J Med. 2011. PMID: 21208106 Clinical Trial.

Similar articles

Treatment of patients with irritable bowel syndrome.
Weinstock LB. Weinstock LB. Am Fam Physician. 2007 Jan 1;75(1):31. Am Fam Physician. 2007. PMID: 17225701 No abstract available.
Antibiotic treatment may ease symptoms of irritable bowel syndrome.
[No authors listed] [No authors listed] Mayo Clin Womens Healthsource. 2011 Jun;15(6):3. Mayo Clin Womens Healthsource. 2011. PMID: 21540786 No abstract available.
Rifaximin for irritable bowel syndrome without constipation.
Krause R, Zollner-Schwetz I, Valentin T. Krause R, et al. N Engl J Med. 2011 Apr 14;364(15):1467; author reply 1468. doi: 10.1056/NEJMc1101839. N Engl J Med. 2011. PMID: 21488771 No abstract available.
Rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2015 Aug 3;57(1474):109-11. Med Lett Drugs Ther. 2015. PMID: 26218792 Review. No abstract available.
Irritable bowel syndrome and small intestinal bacterial overgrowth.
Yamini D, Pimentel M. Yamini D, et al. J Clin Gastroenterol. 2010 Nov-Dec;44(10):672-5. doi: 10.1097/MCG.0b013e3181ef3476. J Clin Gastroenterol. 2010. PMID: 20838236 Review.

See all similar articles

Cited by

A Prospective Evaluation of Ileocecal Valve Dysfunction and Intestinal Motility Derangements in Small Intestinal Bacterial Overgrowth.
Chander Roland B, Mullin GE, Passi M, Zheng X, Salem A, Yolken R, Pasricha PJ. Chander Roland B, et al. Dig Dis Sci. 2017 Dec;62(12):3525-3535. doi: 10.1007/s10620-017-4726-4. Epub 2017 Sep 4. Dig Dis Sci. 2017. PMID: 28871499
Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Li J, Zhu W, Liu W, Wu Y, Wu B. Li J, et al. Medicine (Baltimore). 2016 Jan;95(4):e2534. doi: 10.1097/MD.0000000000002534. Medicine (Baltimore). 2016. PMID: 26825893 Free PMC article. Review.
Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome.
Kasir R, Zakko S, Zakko P, Adler M, Lee A, Dhingra S, Guttermuth C. Kasir R, et al. Dig Dis Sci. 2016 Mar;61(3):846-51. doi: 10.1007/s10620-015-3872-9. Epub 2015 Sep 11. Dig Dis Sci. 2016. PMID: 26362282
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Tojo R, et al. World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163. World J Gastroenterol. 2014. PMID: 25386066 Free PMC article. Review.
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
Lee KN, Lee OY. Lee KN, et al. World J Gastroenterol. 2014 Jul 21;20(27):8886-97. doi: 10.3748/wjg.v20.i27.8886. World J Gastroenterol. 2014. PMID: 25083061 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information